The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD

@inproceedings{Anzueto2017TheEO,
  title={The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD},
  author={Antonio Anzueto and Claus F Vogelmeier and Konstantinos Kostikas and Karen Mezzi and Sebastian Fucile and Giovanni Bader and Steven R. S. Shen and Donald D Banerji and Robert B. Fogel},
  booktitle={International journal of chronic obstructive pulmonary disease},
  year={2017}
}
BACKGROUND Endpoints that evaluate deterioration rather than improvement of disease may have clinical utility in COPD. In this analysis, we compared the effects of different maintenance treatments on the prevention of clinically important deterioration (CID) in moderate-to-severe COPD patients. METHODS Data were analyzed from three 26-week studies comparing indacaterol/glycopyrronium (IND/GLY) with tiotropium (TIO) or salmeterol/fluticasone (SFC). Two definitions of CID were used; each was a… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Long - term outcome following first clinically important deterioration in COPD

  • I Naya, T Tombs, H Mullerova, C Compton, P Jones
  • Eur Respir J
  • 2016

Similar Papers

Loading similar papers…